Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Investigative Ophthalmology and Visual Science

• Publication date

  1997-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/s0002-9394(99)80220-7PMID 9418725
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunohistochemical localization of transforming growth factor-β in human photoreceptors

  2009cited by this paper
• Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.

  1997cited by this paper
• Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells.

  1996cited by this paper
• Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis.

  1996cited by this paper
• Localization of vascular endothelial growth factor in human retina and choroid.

  1996cited by this paper
• Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate.

  1996cited by this paper
• Blood-ocular barrier breakdown in eyes with ocular melanoma. A potential role for vascular endothelial growth factor/vascular permeability factor.

  1995cited by this paper
• Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.

  1995cited by this paper
• Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels.

  1995cited by this paper
• Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.

  1995cited by this paper
• Hypoxic regulation of vascular endothelial growth factor in retinal cells.

  1995cited by this paper
• Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia

  1995cited by this paper
• Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases.

  1995cited by this paper
• Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions.

  1995cited by this paper
• Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy

  1995cited by this paper
• Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability

  1995cited by this paper
• Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy.

  1994cited by this paper
• Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.

  1994cited by this paper
• Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway.

  1994cited by this paper
• Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

  1994cited by this paper
• Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.

  1994cited by this paper
• Quantification of retinal capillary density and flow velocity in patients with essential hypertension.

  1994cited by this paper
• Heterogeneity in localization of isoforms of TGF-beta in human retina, vitreous, and choroid.

  1993cited by this paper
• Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells.

  1993cited by this paper
• A new technique for visualization of the human retinal vasculature.

  1992cited by this paper
• The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules.

  1992cited by this paper
• Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

  1992cited by this paper
• Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.

  1991cited by this paper
• Purification and biological properties of vasculotropin, a new angiogenic cytokine

  1991cited by this paper
• Altered distribution of basic fibroblast growth factor in diabetic retinopathy.

  1991cited by this paper
• The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

  1991cited by this paper
• Immunohistochemical localization of transforming growth factor-beta in human photoreceptors.

  1991cited by this paper
• The vascular endothelial growth factor family of polypeptides

  1991cited by this paper
• Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels

  1991cited by this paper
• Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity

  1990cited by this paper
• Characterization of the receptor to vasculotropin on bovine adrenal cortex-derived capillary endothelial cells.

  1990cited by this paper
• Vascular permeability factor, an endothelial cell mitogen related to PDGF.

  1989cited by this paper
• Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

  1989cited by this paper
• A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.

  1986cited by this paper
• Early breakdown of the blood-retinal barrier in diabetes.

  1975cited by this paper
• The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases

  1948cited by this paper

• Hybrid Cell-Membrane-Coated Biomimetic Nanoparticles for Targeted Noninvasive Intervention in Early Diabetic Retinopathy.

  2025cites this paper
• Specificity of endothelial cells in endothelial dysfunction of diabetic kidney disease and their crosstalk with neighboring cells: an updated review

  2025cites this paper
• Treatment Efficacy of a Dual Release of Aflibercept and Dexamethasone From a Single Hydrogel Drug Delivery System in a Rodent Model

  2025cites this paper
• Changes in Neurodegeneration and Visual Prognosis in Branch Retinal Vein Occlusion after Resolution of Macular Edema

  2024cites this paper
• Modelling neurodegeneration and inflammation in early diabetic retinopathy using 3D human retinal organoids

  2024cites this paper
• 3D human retinal organoid model for the study of early diabetic retinopathy

  2023cites this paper
• The effect of stiffened diabetic red blood cells on wall shear stress in a reconstructed 3D microaneurysm

  2022cites this paper
• Choriocapillaris: Fundamentals and advancements.

  2021cites this paper
• Retinal Vascular Endothelial Cell Dysfunction and Neuroretinal Degeneration in Diabetic Patients

  2021cites this paper
• Retinal Vascular Disease

  2021cites this paper
• The effect of bovine serum albumin-glutaraldehyde and polyethylene glycol polymer on neointimal hyperplasia in rabbit carotid artery anastomosis

  2020cites this paper
• Fibrosis and diabetes: Chronic hyperglycemia triggers organ-specific fibrotic mechanisms

  2020cites this paper
• Comparision of Hyperreflective Foci after Treatment of Diabetic Macular Edema Patients between Intravitreal Injections

  2020cites this paper
• Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities

  2020influential citation
• Connexin43 hemichannel block inhibits NLRP3 inflammasome activation in a human retinal explant model of diabetic retinopathy.

  2020cites this paper
• Quantification of retinal microvasculature and neurodegeneration changes in branch retinal vein occlusion after resolution of cystoid macular edema on optical coherence tomography angiography

  2019cites this paper
• Characterization of Biodegradable Microsphere-Hydrogel Ocular Drug Delivery System for Controlled and Extended Release of Ranibizumab

  2019cites this paper
• Electroretinographic evidence suggesting that the type 2 diabetic retinopathy of the sand rat Psammomys obesus is comparable to that of humans

  2018cites this paper
• Proteolytic cleavage of vascular adhesion protein-1 induced by vascular endothelial growth factor in retinal capillary endothelial cells

  2018cites this paper
• Interocular Asymmetry of the Ganglion Cell-inner Plexiform Layer in Diabetic Retinopathy.

  2018cites this paper
• NAP counteracts hyperglycemia/hypoxia induced retinal pigment epithelial barrier breakdown through modulation of HIFs and VEGF expression

  2018cites this paper
• Microglia enhanced the angiogenesis, migration and proliferation of co-cultured RMECs

  2018cites this paper
• The unfolded protein response signaling and retinal Müller cell metabolism

  2018cites this paper
• F-36316 A and B, novel vasoactive compounds, isolated from Incrucipulum sp. SANK 10414

  2017cites this paper
• TNFα-Induced Disruption of the Blood-Retinal Barrier In Vitro Is Regulated by Intracellular 3',5'-Cyclic Adenosine Monophosphate Levels.

  2017cites this paper
• Immunohistochemical Characterization of Connexin43 Expression in a Mouse Model of Diabetic Retinopathy and in Human Donor Retinas

  2017cites this paper
• Study of the effects of β-adrenergic receptor agonists and antagonists on pericyte survival in retinopathies

  2017influential citation
• Retinal oxygen: from animals to humans.

  2017cites this paper
• Vestaines, novel vasoactive compounds, isolated from Streptomyces sp. SANK 63697

  2016cites this paper
• Morphologic Changes in Patient with Drusen and Drusenoid Pigment Epithelial Detachment after Intravitreal Ranibizumab for Choroidal Neovascular Membrane : A Case Report

  2016cites this paper
• Surface plasmon resonance analysis.

  2016cites this paper
• Retinal ganglion cell neuronal damage in diabetes and diabetic retinopathy

  2016cites this paper
• Accelerated degradation of collagen membranes in diabetic rats is associated with increased infiltration of macrophages and blood vessels

  2016cites this paper
• A Novel Natural Product-Derived Compound, Vestaine A1, Exerts both Pro-Angiogenic and Anti-Permeability Activity via a Different Pathway from VEGF

  2016cites this paper
• The Application of Stimuli‐Responsive VEGF‐ and ATP‐Aptamer‐Based Microcapsules for the Controlled Release of an Anticancer Drug, and the Selective Targeted Cytotoxicity toward Cancer Cells

  2016cites this paper
• Hypergravity Effects on the Retina and Intraocular Pressure in Mice.

  2016cites this paper
• Autophagy in Diabetic Retinopathy

  2016cites this paper
• Vitreous humor in the pathologic scope: Insights from proteomic approaches

  2015cites this paper
• Synergistic protective effects of escin and low‑dose glucocorticoids against vascular endothelial growth factor‑induced blood‑retinal barrier breakdown in retinal pigment epithelial and umbilical vein endothelial cells.

  2015cites this paper
• Common Sequence Variation in the VEGFC Gene Is Associated with Diabetic Retinopathy and Diabetic Macular Edema.

  2015cites this paper
• Hypoxia and Dark Adaptation in Diabetic Retinopathy: Interactions, Consequences, and Therapy

  2015cites this paper
• Current knowledge on diabetic retinopathy from human donor tissues.

  2015cites this paper
• Oxygen and glucose deprivation on human Müller cells (MIO-M1) and human organotypic retinal cultures (HORCs) in relation to glaucoma

  2015cites this paper
• Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy

  2015cites this paper
• Quantitative retinal blood flow mapping from fluorescein videoangiography using tracer kinetic modeling.

  2015cites this paper
• The role of CTGF in diabetic retinopathy.

  2015cites this paper
• International Journal of Basic and Applied Physiology

  2014cites this paper
• Hyperglycemia Induces Toll-Like Receptor-2 and -4 Expression and Activity in Human Microvascular Retinal Endothelial Cells: Implications for Diabetic Retinopathy

  2014cites this paper
• In vitro and ex vivo retina angiogenesis assays

  2014cites this paper
• Functional and morphological changes in diabetic macular edema over the course of anti‐vascular endothelial growth factor treatment

  2013cites this paper
• The effects of bisphosphonates on taurine transport in retinal capillary endothelial cells under high glucose conditions.

  2013cites this paper
• Assessment of retinal vascular geometry in normal and diabetic subjects

  2013cites this paper
• Letter to Editor

  2013cites this paper
• Advantages of Psammomys obesus as an Animal Model to Study Diabetic

  2012cites this paper
• Vascular endothelial growth factor in the ischemic retina and its regulation by somatostatin

  2012cites this paper
• Suppression of VEGF and Decrease in Vascular Leakage by Pyridoxal 5'-Phosphate in Diabetic Rats

  2012cites this paper
• Oxygen Measurements in Animals

  2012cites this paper
• Prospectives for Gene Therapy of Retinal Degenerations

  2012cites this paper
• ANTIANGIOGENIC DRUGS USED FOR THE TREATMENT OF EYE DISEASES

  2012cites this paper
• Prophylactic Medical Treatment of Diabetic Retinopathy

  2012influential citation
• Retinal and Choroidal Vasculature

  2012cites this paper
• Diabetes & Metabolism Advantages of Psammomys obesus as an Animal Model to Study Diabetic Retinopathy

  2012cites this paper
• Vegfa Protects the Glomerular Microvasculature in Diabetes

  2012cites this paper
• Antiangiogenic therapy for ischemic retinopathies.

  2012cites this paper
• Potential Therapeutic Roles for Inhibition of the PI3K/Akt/mTOR Pathway in the Pathophysiology of Diabetic Retinopathy

  2011cites this paper
• Effect of VEGF trap on normal retinal vascular development and oxygen-induced retinopathy in the dog.

  2011cites this paper
• A three-pore model describes transport properties of bovine retinal endothelial cells in normal and elevated glucose.

  2011cites this paper
• OXYGEN THERAPY FOR DIABETIC MACULAR ISCHEMIA: A Pilot Study

  2011cites this paper
• Role of Vascular Endothelial Growth Factor-A in Diabetic Kidney Disease

  2011cites this paper
• Subconjunctival Injection of Bevacizumab in the Treatment of Corneal Neovascularization Associated With Lipid Deposition

  2011cites this paper
• Structure-function relationships of PEDF.

  2010cites this paper
• Retinal vascular permeability in diabetes

  2010cites this paper
• Immunohistochemical localization of low density lipoprotein receptor-related protein 1 and alpha(2)-Macroglobulin in retinal and choroidal tissue of proliferative retinopathies.

  2010cites this paper
• ANGIOGENIC AND INFLAMMATORY MARKERS IN THE INTRAOCULAR FLUID OF EYES WITH DIABETIC MACULAR EDEMA AND INFLUENCE OF THERAPY WITH BEVACIZUMAB

  2010cites this paper
• Increased levels of vascular endothelial growth factor in the aqueous humor of patients with diabetic retinopathy

  2010influential citation
• Blood-retinal barrier glycerol permeability in diabetic macular edema and healthy eyes: estimations from macular volume changes after peroral glycerol.

  2010cites this paper
• Therapeutic monoclonal antibodies in ophthalmology.

  2009cites this paper
• Gene expression patterns in hypoxic and post-hypoxic adult rat retina with special reference to the NMDA receptor and its interactome

  2009cites this paper
• Serum VEGF increases in diabetic polyneuropathy, particularly in the neurologically active symptomatic stage

  2009cites this paper
• Intravitreal Triamcinolone Acetonide Inhibits Breakdown of the Blood-Retinal Barrier Through Differential Regulation of VEGF-A and Its Receptors in Early Diabetic Rat Retinas

  2008cites this paper
• Fibrosis in diabetes complications: Pathogenic mechanisms and circulating and urinary markers

  2008cites this paper
• Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management.

  2008cites this paper
• Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits.

  2008cites this paper
• Diabetic Retinopathy, Inflammation, and Proteasome

  2007cites this paper
• Vascular permeability in ocular disease and the role of tight junctions

  2007cites this paper
• Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients

  2007cites this paper
• Inhibiteur de néovascularisation fibreuse oculaire

  2007cites this paper
• Effect of VEGF-A on expression of profibrotic growth factor and extracellular matrix genes in the retina.

  2007cites this paper
• Spatial and temporal distribution of growth factors and their receptors in diabetic retinopathy

  2007cites this paper
• Estudio piloto de cirugía combinada de facoemulsificación y vitrectomía calibre 25 asistida con triamcinolona y bevacizumab en pacientes con catarata y edema macular diabético difuso

  2007cites this paper
• Role of protein kinase C inhibition in the development of diabetic microvascular complications

  2007cites this paper
• Progression of retinopathy in type 1 diabetic women during pregnancy.

  2007cites this paper
• Stimulation of apical and basolateral VEGF-A and VEGF-C secretion by oxidative stress in polarized retinal pigment epithelial cells.

  2006cites this paper
• Differential Expression of Vitreous Proteins in Proliferative Diabetic Retinopathy

  2006cites this paper
• Effect of insulin on the expression of intraocular vascular endothelial growth factor in diabetic rats.

  2006cites this paper
• Thiol regulation of vascular endothelial growth factor-A and its receptors in human retinal pigment epithelial cells.

  2006cites this paper
• Feline models of type 2 diabetes mellitus.

  2006cites this paper
• Stimulation of apical and basolateral vascular endothelial growth factor-A and vascular endothelial growth factor-C secretion by oxidative stress in polarized retinal pigment epithelial cells

  2006influential citation
• Effects of triamcinolone on the expression of VEGF and PEDF in human retinal pigment epithelial and human umbilical vein endothelial cells.

  2006cites this paper
• Hyperbaric oxygen therapy ameliorates the blood–retinal barrier breakdown in diabetic retinopathy

  2006cites this paper